Interferon-beta prevents antigen-induced bronchial inflammation and airway hyperreactivity in mice

Pharmacology

Volumn 55, Issue 1, 1997, Pages 32-43

  Maeda, Yoshizou ^a   Musoh, Keiichi ^a   Shichijo, Michitaka ^a   Tanaka, Hiroyuki ^a   Nagai, Hiroichi ^a  

^a Gifu Pharmaceutical University   (United States)

Author keywords

Airway hyperreactivity; Bronchial inflammation; Interferon ; Prednisolone; T helper type 2 cell D10G4.1

Indexed keywords

ACETYLCHOLINE; IMMUNOGLOBULIN E ANTIBODY; OVALBUMIN; PREDNISOLONE; RECOMBINANT BETA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; EOSINOPHILIA; HELPER CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE CLONE; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030748776     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139510     Document Type: Article

References (33)

1. Djukanovic R. Roche W, Wilson J, Beasley C. Twentyman O. Holgate ST: Mucosal inflammation in asthma. Am Rev Respir Dis 1990:142: 434-457.
2. Kay AB: Asthma and inflammation. J Allergy Clin Immunol 1990:87: 893-910.
3. Bousquet J. Chancz P. Lacoste JY. Barneon G, Ghavanian N. Enander I. Venge P, Ahlstcdt S. Simony-La-fontaine J, Godard P. Michel FB: Eosinophilie inflammation in asthma. N Engl J Med 1990:323:1033-1039.
4. Walker C, Kaegi M. Braun P. Blaser K: Activated T cells and eosino-philia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-942.
5. Holgate ST: Mediator and cytokine mechanisms in asthma. Thorax 1993;48:103-109.
6. Van Oosterhout AJM, Nijkamp FP: Role of cytokines in bronchial hyperresponsiveness. Pulm Pharmacol 1993;6:225-236.
7. Schlcimer RP: Glucocorticoids: Their mechanism of action and use in allergic diseases: in Middleton E. Reed CE. Ellis EF. Adkinson JNF, Yunginger JW. Busse W (eds): Allergy Principles and Practice. Si Louis. Mosby, 1993, pp 893-925.
8. Barnes PJ: Inhaled glucocorticoids for asthma. N Engl.I Med 1995:332: 868-875.
9. Barnes PJ: Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 1995;97(suppl):159-168.
10. Iwamoto I. Nakajima H. Endo H. Hoshida S: Interferon-y regulates antigen-induced eosinophil recruitment into the mouse airway by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993:177:573-576.
11. Kung TT, Stelts DM, Zurcher JA, Watnick AS, Jones H. Mauser PJ, Fernandez X. Umland S, Kreutner W. Chapman RW. Egan RW: Mechanisms of allergic pulmonary cosin-ophilia in the mouse. J Allergy Clin Immunol 1994;94:1217-1224.
12. Nakajima H. Nakao A, Watanabc Y, Yoshida S, Iwamoto I: IFN-a inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. J Immunol 1994:153:1264-1270.
13. Parronchi P. Dc Carli M, Manctt i R. Simonelli C. Sampognaro S, Piccin-ni MP. Macchia D. Maggi E. Del Prete G. Romagani S: IL-4 and IFN (a and y) exert opposite regulatory effects on the development of cytolytic potential by Th 1 orTh2 human T cell clones. J Immunol 1992; 149: 2977-2983.
14. Finkclman FD. Svctic A. Grosser I, Snapper C, Holmes J. Trotta PP, Katona IM. Cause WC: Regulation by interferon a of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med I991;174:1179-1188.
15. 2. Proc Natl Acad Sci USA 1988: 85:6880-6884.
16. The Interferon Nomenclature Committee: Interferon nomenclature. Arch Virol 1983;77:283-285.
17. Grosser I. Brouty-Boye D. Thomas MT. Macieria-Cochlho A: Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations. Proc Natl Acad Sci USA 1970:66:1052-1058.
18. Ling PD. Warren MK. Vogel SN: Antagonistic effect of interferon-P on the interferon-7-induced expression of la antigen in murine macrophages. J Immunol 1985:135:1857-1863.
19. Vogel SN. English KE. Fertsch D. Fultz MJ: Differential modulation of macrophage membrane markers by interferon: Analysis of Fc and C3b receptors, Mac-1, and la antigen expression. J Interferon Res 1983:3:153-160.
20. Agucl M. Blanchard B: High affinity binding of '-'I-labelcd mouse interferon to a specific cell surface receptor. II. Analysis of binding properties. Virology 1981; 115:249-261.
21. Branca AA, Baglioni C: Evidence that type 1 and II interferons have different, receptors. Nature 1981: 294:768-770.
22. Nagai H. Yamaguchi S. Inagaki N. Tsuruoka N. Hitoshi Y. Takatsu K: Effect of anti-IL-5 monoclonal antibody on allergic bronchial cosino-philia and airway hyperresponsive-ness in mice. Life Sci 1993:53:243-247.
23. Yamaguchi S. Nagai N, Tanaka H. Tsujimoto M. Tsuruoka N: Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci 1994;54:471-475.
24. Nagai H, Yamaguchi S, Tanaka I I, Inagaki N: Effect of some immuno-supressants on airway hyperreactivity in mice. Int Arch Allergy Immunol 1995:108:189-195.
25. Nagai H. Yamaguchi S. Maeda Y. Tanaka H: The effect of mast cells, eosinophils and IL-5 on airway hyperreactivity to acetylcholine in mice. Clin Exp Allergy 1996:26: 642-647.
26. 71-77.
27. Kaye J. Porcelli S, Tite J. Jones B, Janeway CA: Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J Exp Med 1983:158:836-856.
28. Yamaya H. Basaki Y. Togawa M, Kojima M. Kiniwa M. Matsuura N: Down-regulation of Th2 cell-mediated murine peritoneal eosino-philia by antiallergic agents. Life Sci 1995:56:1647-1654.
29. Klimpel GR. Flcischmann WR. Klimpel KD: Interferon-gamma (IFN-y) and IFN-a/ß suppress murine myeloid colony formation (CFU-C): Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol 1982:129:76-80.
30. Greenberg FIB. Pollard RB. Lutiv-ick KI, Gregory PB, Robinson WB. Merigan TC: Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 1976: 295:517-522.
31. Schändend L. Del Proie GF. Cogan E, Stordeur P. Crusiaux A, Kennes B. Romagnani S, Goldman M: Recombinant interferon-alpha selectively inhibits the production of in-terleukin-5 by human CD4+ T cells. J Clin Invest 1996:97:309-315.
32. Zuany-Amorim C. Leduc D. Vargaf-tig BB. Pretolani M: Modulation by rm interferon-y and CD4+ T-lym-phocytes of allergic eosinophil accumulation in the mice peritoneal cavity. Ann NY Acad Sci 1994:725:34-43.
33. Boguniewicz, M. Schneider LC. Mil-grom H. Newell D. Kelly N, Tam P, Izu A, Jaffe HS. Bucalo LR. Leung DYM: Treatment of steroid-resistant asthma with recombinant interferon-gamma. Clin Exp Allergy 1993;23:785-790.